From April 1, 2023 to June 30, 2023, the company has repurchased 368,809 shares, representing 1.2% for $0.56 million. With this, the company has completed the repurchase of 4,559,479 shares, representing 13.81% for $15.26 million under the buyback announced on March 15, 2022.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.16 USD | -0.85% | +0.87% | -12.78% |
Apr. 12 | Co-Diagnostics, Inc. Inaugurates New Manufacturing Facility in Utah with Ribbon Cutting Event | CI |
Apr. 04 | Co-Diagnostics, Inc. Appoints Executive Appointments | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-12.78% | 36.57M | |
-15.28% | 19.22B | |
-44.98% | 2.63B | |
+17.00% | 1.86B | |
-0.51% | 1.66B | |
+25.65% | 1.23B | |
-13.90% | 1.05B | |
-21.76% | 894M | |
-3.53% | 740M | |
-20.73% | 687M |
- Stock Market
- Equities
- CODX Stock
- News Co-Diagnostics, Inc.
- Tranche Update on Co-Diagnostics, Inc.'s Equity Buyback Plan announced on March 15, 2022.